MedPath

Clitoral Reconstruction (CR) in FGM/C Patients

Completed
Conditions
Female Genital Mutilation / Cutting (FGM/C)
Registration Number
NCT05026814
Lead Sponsor
University Hospital, Basel, Switzerland
Brief Summary

Surgical interventions to reconstruct the vulva together with psychosexual care have been proposed as a multidisciplinary care concept for women who have undergone female genital mutilation/cutting (FGM/C).

This cross-sectional study is to assess the experiences of multidisciplinary care of women who request CR at Geneva University Hospital (HUG) in order to analyze the expectations and motivations for clitoral reconstruction, to study the reasons for deciding against or in favor of CR and to study the outcome of the care received (CR+ psychosexual care versus psychosexual care alone) in sexual response, eventual dyspareunia, genital self-image and overall satisfaction through questionnaires.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
20
Inclusion Criteria
  • Signed informed consent of the present study
  • French and / or English speaking
Exclusion Criteria
  • Insufficient knowledge of project language (French/English)
  • No informed consent
  • Inability to sign consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
General satisfaction with multidisciplinary careone time assessment at baseline

General satisfaction with multidisciplinary care rated on a scale from 0 to 10 (0=totally unsatisfied, 10: totally satisfied)

Secondary Outcome Measures
NameTimeMethod
General satisfaction with subdomain psychosexual careone time assessment at baseline

General satisfaction with subdomain psychosexual care rated on a scale from 0 to 10 (0=totally unsatisfied, 10: totally satisfied)

General satisfaction after CR with female identityone time assessment at baseline

General satisfaction after CR with female identity rated on a scale from 0 to 10 (0=totally unsatisfied, 10: totally satisfied)

General satisfaction with subdomain CR and psychosexual careone time assessment at baseline

General satisfaction with subdomain CR and psychosexual care rated on a scale from 0 to 10 (0=totally unsatisfied, 10: totally satisfied)

General satisfaction with subdomain CR aloneone time assessment at baseline

General satisfaction with subdomain CR alone rated on a scale from 0 to 10 (0=totally unsatisfied, 10: totally satisfied)

General satisfaction after CR with sexual responseone time assessment at baseline

General satisfaction after CR with sexual rated on a scale from 0 to 10 (0=totally unsatisfied, 10: totally satisfied)

General satisfaction after CR with genital imageone time assessment at baseline

General satisfaction after CR with genital rated on a scale from 0 to 10 (0=totally unsatisfied, 10: totally satisfied)

General satisfaction after CR with painone time assessment at baseline

General satisfaction after CR with pain rated on a scale from 0 to 10 (0=totally unsatisfied, 10: totally satisfied)

Female Genital Self Image Scale (FGSIS)one time assessment at baseline

The FGSIS is a measurement instrument consisting of seven items to assess female genital self-image. The questions relate to women's feelings and beliefs about their own genitals. A total score is calculated using a four-point response scale (strongly agree, agree, disagree, and strongly disagree).

World Health Organization (WHO)-Five Well-Being Indexone time assessment at baseline

The WHO-Five Well-Being Index is a questionnaire consisting of five questions to assess wellbeing. For each question, scores from 0 to 5 can be given. By adding up the values for the answers, a total value is obtained, whereby a low total value corresponds to low well-being

Trial Locations

Locations (1)

University Hospital of Geneva (HUG), Department of Obstetrics and Gynecology

🇨🇭

Genève, Switzerland

University Hospital of Geneva (HUG), Department of Obstetrics and Gynecology
🇨🇭Genève, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.